Presentation

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Presenter: 204599|MP Bonaca

June 22, 2012

REGISTER for free or LOG IN to view this content

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

CAD Pharma

Coronary

Factoid

Up Next

Presentation

Should We Still Be Concerned About Stent Thrombosis With CoCr-EES?

Presenter: 138230|Srihari Naidu

June 22, 2012

More slides +

Presentation

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Presenter: Elisabet Nikolic

June 25, 2012

Presentation

Silent Cerebral Infarcts After Cardiac Catheterization

Presenter: Martial Hamon

June 26, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.